novo nordisk cuts prices for its glp-1 drugs. Yes, you heard that right β Zepbound just got a major price drop. π, Eli Lilly said βnew year, new numbers,β and honestlyβ¦ weβre here it. Lower cost, same powerful results for metabolic health and Novo Nordisk cuts Wegovy and
Description
Personality features in obesity
Recent evidence showed that Tirzepatide (TZP), a new drug including both Glucagon Like Peptide 1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) receptor agonism, is effective in subjects with type 2 diabetes (T2D), lowering body weight, fat mass and glycated hemoglobin (HbA 1c ) also in obese or overweight adults without T2D
British Journal of Nutrition
The risk of self-harm fell by 44%
Research is continuously investigating new multi-receptor agonists that may provide improved therapeutic advantages while ensuring acceptable safety profiles
Positron emission tomography of patients with early PD showed a significant increase in the activation of microglia (68), which might lead to neuron loss in PD and AD (69)
